Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ergocalciferol 4,500units/5ml oral liquid
0906040N0AAASAS
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergocalciferol 400,000units/2ml inj ampoules
0906040N0AAFEFE
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergocalciferol 400,000units/5ml oral liquid
0906040N0AAETET
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergocalciferol 400units/5ml oral liquid
0906040N0AADHDH
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergocalciferol 5,000units/5ml oral suspension
0906040N0AADFDF
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergocalciferol 500units/5ml oral liquid
0906040N0AADQDQ
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergocalciferol 6,000units/5ml oral suspension
0906040N0AAEIEI
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergocalciferol 600units/5ml oral suspension
0906040N0AADZDZ
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergocalciferol 7,500units/5ml oral suspension
0906040N0AADRDR
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergocalciferol 75,000units/5ml oral suspension
0906040N0AADNDN
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergocalciferol 800units/5ml oral suspension
0906040N0AAEFEF
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergocalciferol 900units/5ml oral liquid
0906040N0AAEGEG
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergoral D2 5,000unit tablets
0906040N0BYABAP
|
Ergoral D2 | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergoral D2 50,000unit capsules
0906040N0BYADFL
|
Ergoral D2 | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergoral D2 500unit tablets
0906040N0BYAAEW
|
Ergoral D2 | Ergocalciferol | Nutrition and Blood | No data available |
|
Essentials Evening Primrose Oil + Starflower Oil 1000mg caps
091200000BFSCA0
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Essentials Evening Primrose Oil + Starflower Oil 500mg caps
091200000BFSBA0
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Everfresh 100% organic rye sourdough bread unsliced
0904010U0BXACAA
|
Everfresh (Gluten free bread) | Gluten free/wheat free bread | Nutrition and Blood | No data available |
|
Everfresh gluten free mixed grain sourdough bread
0904010H0CJAAAA
|
Everfresh (G/F Bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Everfresh organic rye bread with poppy seeds unsliced
0904010U0BXABAA
|
Everfresh (Gluten free bread) | Gluten free/wheat free bread | Nutrition and Blood | No data available |
|
Everfresh organic rye bread with sunflower seeds unsliced
0904010U0BXADAA
|
Everfresh (Gluten free bread) | Gluten free/wheat free bread | Nutrition and Blood | No data available |
|
Everose 660mg tablets
0905022C0BEAAAG
|
Everose | Calcium acetate | Nutrition and Blood | No data available |
|
Evrenzo 100mg tablets
0901030U0BBADAD
|
Evrenzo | Roxadustat | Nutrition and Blood | No data available |
|
Evrenzo 150mg tablets
0901030U0BBAEAE
|
Evrenzo | Roxadustat | Nutrition and Blood | No data available |
|
Evrenzo 20mg tablets
0901030U0BBAAAA
|
Evrenzo | Roxadustat | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.